Namely, CRP represents an inflammatory biomarker and risk predictor in insulin resistance, progressive visual impairment, age‐related macular degeneration, neurodegenerative disorders with associated motor symptoms, and autoimmune disorders like rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). Here, CRP is linked to autoimmune disease.